Researchers report the decoding of the secretome of clinical trial-biobanked cardiopoietic cells and link innate secretome traits with therapeutic outcomes
A recent review article discusses the therapeutic benefit of exosomes secreted by stem and progenitor cells in preclinical models of ischemic heart disease
Despite the considerable interest in defining the transcriptional profiles of human cardiac cells at single‐cell resolution, data regarding the transient stages of early human cardiac progenitor cell development have remained elusive.
New research highlights the zinc-finger of the cerebellum 2 (ZIC2) gene as an essential factor in the formation of human cardiac progenitor cells from embryonic stem cells
A study reveals proteome remodeling within the infarcted heart and establishes that cardiopoietic stem cell therapy can reverse disease-associated proteomic changes